Related Experiment Videos
Adenosine A2 receptor-mediated excitatory actions on the nervous system
1Laboratory of Pharmacology, Gulbenkian Institute of Science, Portugal.
Progress in Neurobiology
|February 1, 1996
Summary
Adenosine A2 receptors, particularly A2a subtypes, are widespread in the brain and influence neurotransmitter release and neuronal activity. Their modulation offers potential therapeutic benefits for neurological disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Adenosine A2 receptors (A2R) are key modulators of neuronal function.
- The distribution and subtypes (A2a and A2b) of A2R in the nervous system are not fully elucidated.
- Understanding A2R roles is crucial for developing treatments for neurological conditions.
Purpose of the Study:
- To review the distribution, molecular structure, and functional roles of adenosine A2 receptors in the nervous system.
- To highlight the potential therapeutic applications of targeting A2 receptors.
Main Methods:
- Literature review of studies employing ligand binding, functional assays, and genetic techniques.
- Analysis of receptor distribution across various brain regions and cell types.
- Examination of A2R interactions with other neurotransmitter systems.
Main Results:
- Adenosine A2a receptors are found in the striatum, hippocampus, cortex, and other neural structures.
- A2b receptors are identified in glial and neuronal cells with potentially widespread brain distribution.
- A2R activation influences neurotransmitter release (acetylcholine, glutamate, noradrenaline, GABA), neuronal excitability, synaptic plasticity, and behavior.
- A2R interact with dopamine, adenosine A1, CGRP, glutamate, and nicotinic receptors, expanding adenosine's influence on neuronal function.
Conclusions:
- Adenosine A2 receptors play a significant role in regulating nervous system activity.
- Targeting A2 receptors shows therapeutic promise for movement disorders (Parkinson's, Huntington's), schizophrenia, Alzheimer's disease, and myasthenia gravis.